These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Flow cytometry with or without cytochemistry for the diagnosis of acute leukemias?
    Author: Kheiri SA, MacKerrell T, Bonagura VR, Fuchs A, Billett HH.
    Journal: Cytometry; 1998 Apr 15; 34(2):82-6. PubMed ID: 9579605.
    Abstract:
    Ninety-three (93) cases of acute leukemia were assessed using flow cytometry and cytochemistry and assigned to one of four categories: myeloid, lymphoid, biphenotypic, and non-diagnostic. In leukemias designated as ALL or AML by both methodologies, there was lineage agreement in all but 3 of 71 cases (95.8%). However, when nondiagnostic or biphenotypic diagnoses made by either methodology were included, complete agreement occurred in only 77.4% of cases. Of 37 cases designated myeloid origin by flow cytometry, 33 (89.2%) were read as myeloid by cytochemistry. The four discordant diagnosis were read as lymphoid (2) or as non-diagnostic (2). Eighty percent of lymphoid leukemias were diagnosed as such by both flow cytometry and cytochemistry; one early B cell ALL was diagnosed as myeloid and 8 as non-diagnostic. Fifty percent (50%) of flow cytometry defined T-cell ALL were considered non-diagnostic by cytochemistry as compared to 17% of the total ALL group. Of the remaining four designated non-T cell ALL by flow cytometry and non-diagnostic by cytochemistry, three were read by flow cytometry to be standard pre-B ALL and one an early B-cell ALL. Only 2/9 leukemias considered biphenotypic by flow were identified as such by cytochemistry. Given (1) the potential importance of non-lineage expression in the prognosis of myeloid and lymphoid leukemias, (2) cytochemistry's impaired ability to diagnose biphenotypic, T-cell, and promyelocytic leukemias, and (3) the increased costs incurred in diagnosis when both modalities are used, perhaps it is time to re-examine the utility of performing both flow cytometry and cytochemistry as initial testing for leukemia categorization.
    [Abstract] [Full Text] [Related] [New Search]